First Bancorp’s Bristol-Myers Squibb BMY Stock Holding History

First Bancorp’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$440K	Sell	7,257 -25	-0.3%	-$1.46K	0.22%	85
2025 Q4	$393K	Buy	7,282 +1,166	+19%	+$56.1K	0.21%	91
2025 Q3	$276K	Sell	6,116 -105	-2%	-$4.9K	0.15%	113
2025 Q2	$288K	Sell	6,221 -64	-1%	-$3.14K	0.17%	106
2025 Q1	$383K	Hold	6,285	–	–	0.25%	88
2024 Q4	$355K	Sell	6,285 -138	-2%	-$7.71K	0.24%	94
2024 Q3	$332K	Hold	6,423	–	–	0.23%	94
2024 Q2	$267K	Buy	6,423 +500	+8%	+$22.4K	0.2%	100
2024 Q1	$321K	Buy	5,923 +805	+16%	+$41K	0.24%	88
2023 Q4	$263K	Hold	5,118	–	–	0.21%	98
2023 Q3	$297K	Buy	5,118 +134	+3%	+$8.21K	0.26%	83
2023 Q2	$319K	Sell	4,984 -98	-2%	-$6.57K	0.26%	82
2023 Q1	$352K	Sell	5,082 -200	-4%	-$14.1K	0.3%	74
2022 Q4	$380K	Sell	5,282 -380	-7%	-$28.7K	0.32%	69
2022 Q3	$403K	Sell	5,662 -295	-5%	-$21.4K	0.37%	63
2022 Q2	$459K	Sell	5,957 -65	-1%	-$4.95K	0.43%	54
2022 Q1	$440K	Sell	6,022 -60	-1%	-$4.03K	0.4%	52
2021 Q4	$379K	Hold	6,082	–	–	0.33%	59
2021 Q3	$360K	Buy	+6,082	New	+$401K	0.34%	61
2021 Q1	$371K	Buy	+5,889	New	+$366K	0.37%	59

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Bancorp's BMY Position: Q1 2026 in Review

First Bancorp reduced its Bristol-Myers Squibb (BMY) stake by 0.34% in Q1 2026, selling an estimated $1.46K and leaving 7,257 shares worth $440K. The position accounts for 0.22% of the portfolio, ranked #85.

First Bancorp first reported a position in BMY in Q1 2021 and has held it in 20 quarters since. The position peaked at $459K in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

First Bancorp held 7,257 shares of Bristol-Myers Squibb worth $440K as of Q1 2026.
First Bancorp sold 25 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.46K.
Bristol-Myers Squibb made up 0.22% of First Bancorp's portfolio in Q1 2026, its #85 holding.
First Bancorp first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 20 quarters since.
First Bancorp's Bristol-Myers Squibb position peaked at $459K in Q2 2022.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on First Bancorp's 13F filing for Q1 2026, filed 20 Apr 2026.